Keyphrases
Phosphatidylinositol 3-kinase Inhibitor
100%
Insulin Secretion
100%
Unique Mechanism
100%
Insulinoma Cells
100%
LY294002
60%
Wortmannin
40%
Action Potential Duration
40%
Akt Phosphorylation
20%
Glucose Concentration
20%
Type 2 Diabetes Mellitus (T2DM)
20%
Phosphoinositide 3-kinase (PI3K)
20%
Membrane Potential
20%
Pancreatic Cells
20%
Insulin Resistance
20%
Acute Treatment
20%
Insulin
20%
Voltage Gating
20%
Hyperinsulinemia
20%
Voltage-gated Potassium Channel
20%
Treatment Conditions
20%
Insulin Release
20%
Calcium Current
20%
Onodi Cell
20%
Neuroscience
Phosphoinositide 3-Kinase Inhibitor
100%
LY294002
100%
Action Potential
66%
Wortmannin
66%
In Vitro
33%
Diabetes Mellitus
33%
Membrane Potential
33%
Potassium Channel
33%
Phosphoinositide 3-Kinase
33%
Hyperinsulinemia
33%
Calcium Current
33%
Medicine and Dentistry
Insulin Release
100%
Nesidioblastosis
100%
Phosphoinositide 3-Kinase Inhibitor
100%
LY294002
50%
Action Potential Duration
33%
Wortmannin
33%
Maturity Onset Diabetes of the Young
16%
Membrane Potential
16%
In Vitro
16%
Insulin Resistance
16%
Potassium Channel
16%
Phosphoinositide 3-Kinase
16%
Hyperinsulinemia
16%
Calcium Current
16%
Pharmacology, Toxicology and Pharmaceutical Science
2 Morpholino 8 Phenylchromone
100%
Phosphatidylinositol 3 Kinase Inhibitor
100%
Insulinoma
100%
Wortmannin
66%
Potassium Channel
33%
Insulin Resistance
33%
Phosphatidylinositol 3 Kinase
33%
Hyperinsulinemia
33%
Non Insulin Dependent Diabetes Mellitus
33%
Biochemistry, Genetics and Molecular Biology
Phosphoinositide 3-Kinase Inhibitor
100%
Insulin Release
100%
LY294002
50%
Electric Potential
33%
Action Potential Duration
33%
Enzyme
16%
Insulin Resistance
16%
Potassium Channel
16%
Phosphoinositide 3-Kinase
16%
Membrane Potential
16%
Calcium Current
16%